GlassScriptPhysician profile
Chadi Diab
NPI 1447666219
$11,680.64
in general payments reported to CMS, 2019-2025
8 companies · $4,753 in 2025
The $4,753 reported for 2025 was more than what 85% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $153 · 2021: $755 · 2022: $2,866 · 2023: $2,815 · 2024: $340 · 2025: $4,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,507 · Travel and Lodging: $3,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,507.08 |
| Travel and Lodging | $3,400.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,027.99 | 2022-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Icefx Cryoablation System, Embold Fibered |
| Sirtex Medical INC | $2,097.46 | 2020-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Penumbra, INC. | $2,009.86 | 2022 | |
| Medtronic, INC. | $1,773.85 | 2022-2025 | Osteocool Rf Ablation System, Emprint, Abre |
| Inari Medical, INC. | $467.15 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $136.52 | 2025 | Azur Cx Detachable |
| Abbott Laboratories | $88.56 | 2021 | |
| Bard Peripheral Vascular, INC. | $79.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadi Diab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.